NOSTRUM LABS INC Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NOSTRUM LABS INC, and what generic and branded alternatives to NOSTRUM LABS INC drugs are available?
NOSTRUM LABS INC has fifty approved drugs.
Summary for NOSTRUM LABS INC
| US Patents: | 0 |
| Tradenames: | 47 |
| Ingredients: | 44 |
| NDAs: | 50 |
Drugs and US Patents for NOSTRUM LABS INC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nostrum Labs Inc | ESZOPICLONE | eszopiclone | TABLET;ORAL | 203087-002 | May 8, 2019 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Nostrum Labs Inc | RANITIDINE HYDROCHLORIDE | ranitidine hydrochloride | SYRUP;ORAL | 091091-001 | Sep 20, 2011 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Nostrum Labs Inc | OXYCODONE AND ACETAMINOPHEN | acetaminophen; oxycodone hydrochloride | SOLUTION;ORAL | 201448-001 | Aug 26, 2021 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
